The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122822463 12282246 3 F 20160217 20160721 20160419 20160802 EXP JP-CELGENEUS-JPN-2016043083 CELGENE 75.27 YR F Y 55.00000 KG 20160802 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122822463 12282246 1 PS VIDAZA AZACITIDINE 1 Intravenous drip U 50794 75 MG/M**2 INJECTION QD
122822463 12282246 2 SS VIDAZA AZACITIDINE 1 Intravenous drip U 50794 75 MG/M**2 INJECTION QD
122822463 12282246 3 SS VIDAZA AZACITIDINE 1 Intravenous drip U 50794 75 MG/M**2 INJECTION QD
122822463 12282246 4 C Magmitt MAGNESIUM OXIDE 1 Unknown 0 TABLETS
122822463 12282246 5 C Kinedak EPALRESTAT 1 Unknown 0 UNKNOWN
122822463 12282246 6 C Lendormin D BROTIZOLAM 1 Unknown 0 UNKNOWN
122822463 12282246 7 C Equa VILDAGLIPTIN 1 Unknown 0 UNKNOWN
122822463 12282246 8 C METGLUCO METFORMIN HYDROCHLORIDE 1 Unknown 0 UNKNOWN
122822463 12282246 9 C HUMALOG INSULIN LISPRO 1 Unknown 0 UNKNOWN
122822463 12282246 10 C LANTUS INSULIN GLARGINE 1 Unknown 0 UNKNOWN
122822463 12282246 11 C Sennoside SENNOSIDES 1 Unknown 0 UNKNOWN
122822463 12282246 12 C Sodium Picosulfate SODIUM PICOSULFATE 1 Unknown 0 UNKNOWN
122822463 12282246 13 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 Unknown 0 UNKNOWN
122822463 12282246 14 C MIYA-BM CLOSTRIDIUM BUTYRICUM SPORES STRAIN M-55 1 Unknown 0 UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122822463 12282246 1 Myelodysplastic syndrome
122822463 12282246 4 Product used for unknown indication
122822463 12282246 5 Product used for unknown indication
122822463 12282246 6 Product used for unknown indication
122822463 12282246 7 Product used for unknown indication
122822463 12282246 8 Product used for unknown indication
122822463 12282246 9 Product used for unknown indication
122822463 12282246 10 Product used for unknown indication
122822463 12282246 11 Product used for unknown indication
122822463 12282246 12 Product used for unknown indication
122822463 12282246 13 Product used for unknown indication
122822463 12282246 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122822463 12282246 DE
122822463 12282246 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
122822463 12282246 Cardiac failure
122822463 12282246 Sepsis
122822463 12282246 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122822463 12282246 1 20151215 20151223 0
122822463 12282246 2 20160112 20160121 0
122822463 12282246 3 20160222 20160301 0
122822463 12282246 4 20160113 0